As of 2025-05-25, the Net Margin of Ocumension Therapeutics (1477.HK) is -64.3%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -64.3% |
2023-12-31 | -154.2% |
2022-12-31 | -253.3% |
2021-12-31 | -463.1% |
2020-12-31 | -17294.3% |
2019-12-31 | -690690% |
2018-12-31 | -690690% |
- | |
- | |
- |